Healthcare News
GLP-1 drugs are helpful for children who are living with severe obesity, research finds
Glucagon-like peptide-1 (GLP-1) receptor agonists mimic the action of a hormone called GLP-1 to reduce appetite and feelings of hunger, slow the release of food from the stomach and increase feelings of fullness after eating.
‘We have work to do’: No weight loss benefit with semaglutide before bariatric surgery
Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in JAMA Surgery.
4:3 intermittent fasting produces greater weight loss vs. daily calorie restriction
Adults who fasted 3 nonconsecutive days a week lost more weight vs. those assigned to daily calorie restriction.
Nutrition, exercise guidance with use of obesity medication may help protect muscle mass
Adults with obesity who used medication and received guidance on resistance training and nutrition lost substantially more fat mass than muscle mass, researchers reported in data that will be presented at the European Congress on Obesity.
First weight-loss pill from Lilly shows promising results
Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes lower their blood sugar and lose weight.